Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

  • dorsaVi Secures Breakthrough Memory Tech to Supercharge Sensor Capabilities
    dorsaVi Secures Breakthrough Memory Tech to Supercharge Sensor Capabilities
    • News

  • Australia’s GDP inches higher in March 2025 quarter
    Australia’s GDP inches higher in March 2025 quarter
    • News

  • Soul Patts and Brickworks Strike $14 Billion Deal to Create a Newly Capitalised ASX-Listed Company
    Soul Patts and Brickworks Strike $14 Billion Deal to Create a Newly Capitalised ASX-Listed Company
    • News

  • TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint
    TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint
    • News

Pet-loving tree changers spur a new growth sector for listed vet chain Apiam as demand soars in the pandemic era

  • In News
  • August 10, 2021
  • Tim Boreham
Pet-loving tree changers spur a new growth sector for listed vet chain Apiam as demand soars in the pandemic era

The coronavirus may have inflicted global misery but it’s proven a boon for Apiam Animal Health (ASX: AHX), the only remaining listed veterinary play on the ASX after its nearest peers were taken over by private interests.

As well as spurring panic pet purchasing, the pandemic spurred thousands of Australians to relocate to rural and regional areas where Apiam has a strong presence via its 62 mixed discipline practices.

“They’re certainly different to a typical city-based practice,” says Apiam Founder and CEO, Dr Chris Richards. “They’re a lot larger and many have specialist skills.”

Richards says the tree changers are likely to own not just a dog or a cat, but a horse or a hobby farm as well.

Richards also points to ‘peri-urban’ population growth areas such as Wollongong, Newcastle and Geelong, the latter where Apiam has recently acquired or opened clinics under its Fur Life Vet brand.

“[The demographic shift] certainly helped our business and we are seeing some significant opportunities,” Richards says, adding that the breaking of the drought also spurred demand for production animal services.

Formed from Richards’ Bendigo-based pig veterinary services business, Apiam listed in 2015 having acquired 12 of the biggest rural and regional clinics.

As well as its extensive network of clinics, Apiam supplies third-party and home-brand veterinary products via its own network of vans and four warehouses across the country.

In late 2019 Apiam acquired ACE Laboratory Services, which provides specialist vaccine and diagnostic laboratory services.

The labs take a specific pathogen and engineer a customised vaccine for that farm, in cases where the existing vaccine does not work or is not available.

“This is going to be a high growth industry for the animal health industry globally,” Richards says.

Richards estimates Apiam provides goods and services to about 35% of the nation’s dairy industry, 35% of the pig industry and 65% of the beef feedlot sector.

Its genetic services business delivers porcine semen to the farm gate – and accounts for nearly half of all piglets born in the country.

Richards says the population shift and strategic acquisitions has changed the mix of species the clinics deal with – to the benefit of underlying profit margins.

“Five years ago, we were 60-65% oriented to intensive production animals, now we are 60% weighted to dairy and companion animals,” he says. “These mixed clinics make for a more stable business with a higher margin.”

In terms of attracting and retaining good vets, Covid-19 has proved a mixed blessing.

The pandemic created more work for vets across-the-board, leaving many of them overwhelmed and seeking the support of a larger entity.

“18 months ago there were very few clinics who were selling; now about five to ten practices are contacting us every month,” Richards says.

“There are some unbelievable clinics we never thought we would be in a position to acquire. Normally they would sell down to their junior vets.”

But the extra work and international border closures have exacerbated a vet shortage, which means Apiam needs to go to extra lengths to keep its 200-plus practitioners happy.

An after-hours ‘tele triage’ system – by which vet nurses handle and prioritise incoming calls – resulted in a 50% reduction in after hour calls to vets.

“In a city clinic, the vets knock off at 6pm and the animals get referred to emergency centres,” Richards says.

“In rural and regional Australia vets have to do their own call-outs so it can be really challenging from a work-life balance viewpoint.”

Apiam was also one of the first in the industry to introduce paid parental and volunteer leave.

But above all, Apiam can provide the diversity of experience that vets don’t get in a typical city practice.

“The young vets want to learn quicker, and with our large clinics they have a pathway to do everything, across both small and large animals,” he says.

In the Half Year ended 31 December 2020, Apiam generated a net profit of $2.6 million on revenue of $61.2m, 54% and 9% higher than the previous year.

“We have been able to grow gross profit at a faster rate than we have grown revenue,” Richards says.

“We continue to expand our margins, we have really good cash flow and have consistently paid a dividend.”

Apiam has plenty of debt headroom to continue to make further clinic acquisitions or greenfields developments – and last week confirmed its $2.1m purchase of clinics in Victoria’s Bannockburn and Ballarat which was funded by existing cash and existing debt facilities.

Earlier in the year Apiam acquired several Queensland clinics – most notably the Beaudesert-based specialist equine practice Scenic Rim Vets – for a total $22.3 million.

Richards says Apiam will only build clinics in sites where there is the potential to grow to six to ten vets, generating $6-10 million of annual revenue.

In comparison, a city practice typically turns over around $1-1.5 million.

“We won’t build clinics for the sake of it,” he says. We know they have to be in fast-growing regions where we know that monthly trading can break even within the first 12 months.”

Apiam invites investors to join their mailing list for Company updates and industry research by subscribing here.

 

*Owners of this website are AHX shareholders

  • About
  • Latest Posts
Tim Boreham
Tim Boreham edits The New Criterion
Latest posts by Tim Boreham (see all)
  • Amid dazzling returns, is now the time to join the diamond hunt? - November 10, 2021
  • Two listed ag stocks that promise a bounteous harvest for investors - November 3, 2021
  • ASX-listed e-gaming stocks show promise but are they in the main event? - October 27, 2021
  •  
  •  
  •  
  •  
  • ahx asx ahx
  • Apiam Animal Health
  • Chris Richards
  • fur life vet
  • veterinary clinics
  • veterinatians
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Tim Boreham
Tim Boreham edits The New Criterion
Latest posts by Tim Boreham (see all)
  • Amid dazzling returns, is now the time to join the diamond hunt? - November 10, 2021
  • Two listed ag stocks that promise a bounteous harvest for investors - November 3, 2021
  • ASX-listed e-gaming stocks show promise but are they in the main event? - October 27, 2021

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Boreham
Tim Boreham edits The New Criterion
Latest posts by Tim Boreham (see all)
  • Amid dazzling returns, is now the time to join the diamond hunt? - November 10, 2021
  • Two listed ag stocks that promise a bounteous harvest for investors - November 3, 2021
  • ASX-listed e-gaming stocks show promise but are they in the main event? - October 27, 2021
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.